Curated News
By: NewsRamp Editorial Staff
July 29, 2025
Revolutionizing Cancer Research with Tumoroid-on-a-Chip Webinar
TLDR
- Creative Biolabs' webinar on the tumoroid-on-a-chip platform offers researchers a cutting-edge tool to gain a competitive edge in preclinical cancer drug testing.
- The tumoroid-on-a-chip platform utilizes microfluidic technology to create 3D tumor models that mimic the complexity of solid tumors for more accurate drug testing.
- By advancing tumor modeling technology, Creative Biolabs' webinar contributes to the development of more effective cancer treatments, improving patient outcomes worldwide.
- Discover how Creative Biolabs is transforming cancer research with tumoroid-on-a-chip technology, a breakthrough in mimicking real tumor environments for drug testing.
Impact - Why it Matters
This webinar is a must-attend for professionals in oncology and drug development, as it highlights cutting-edge technologies that promise to bridge the gap between laboratory research and clinical practice. The tumoroid-on-a-chip platform represents a significant advancement in creating more accurate and reliable cancer models, which are crucial for the development of effective treatments and personalized medicine. By attending, participants will gain insights into how these innovations can accelerate drug discovery and improve patient outcomes.
Summary
Creative Biolabs is set to host an enlightening online webinar on August 22, 2025, at 12:00 PM EDT, spotlighting the innovative tumoroid-on-a-chip platform. This microfluidic-based 3D tumor model is designed to offer more physiologically relevant conditions for preclinical testing, a significant leap forward in cancer research. The session will be led by Dr. Mohsen Akbari, a renowned Associate Professor from the University of Victoria and Director of the Laboratory for Innovations in Microengineering (LiME), who brings a wealth of knowledge in tumor microenvironment modeling and tissue engineering. Researchers and professionals in oncology and drug development are encouraged to Register Now for this opportunity to delve into how microfluidic platforms are transforming the landscape of cancer research.
The webinar will cover the evolution from multi-compartment tumor chips to high-throughput tumoroid-on-plate systems, strategies for incorporating cellular heterogeneity and ECM complexity, and the application of these models in immunotherapy screening and preclinical drug testing. Creative Biolabs also showcases its 3D Tumor Modeling portfolio, which includes a variety of platforms like Ex Vivo Tissue Models and Organ-on-a-Chip Models, aimed at enhancing the accuracy of drug response evaluations in a more representative in vitro environment.
Source Statement
This curated news summary relied on content disributed by 24-7 Press Release. Read the original source here, Revolutionizing Cancer Research with Tumoroid-on-a-Chip Webinar
